MYC and ganglioneuroblastoma: The case from the local cohort had a c-MYC amplification and died within a year of disease discovery, while the TARGET case had an unfavourable histology with the diagnostic category “Ganglioneuroblastoma, nodular”, but the patient was alive after > 10 years of follow-up (last follow-up).